Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-126210
Filing Date
2023-12-15
Accepted
2023-12-15 08:30:51
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm2332875-1_s3.htm S-3 606115
2 EXHIBIT 5.1 tm2332875d2_ex5-1.htm EX-5.1 31566
3 EXHIBIT 23.1 tm2332875d2_ex23-1.htm EX-23.1 2338
4 EX-FILING FEES tm2332875d2_ex-filingfees.htm EX-FILING FEES 61061
5 GRAPHIC tm2332875d2_ex5-2img01.jpg GRAPHIC 4850
6 GRAPHIC tm2332875d2_ex5-2img02.jpg GRAPHIC 7003
7 GRAPHIC tm2332875d2_ex5-2img03.jpg GRAPHIC 7003
8 GRAPHIC tm2332875d2_ex5-2img04.jpg GRAPHIC 7003
9 GRAPHIC tm2332875d2_ex5-2img05.jpg GRAPHIC 7003
  Complete submission text file 0001104659-23-126210.txt   748257
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276057 | Film No.: 231488860
SIC: 2834 Pharmaceutical Preparations